NIH-funded research R01 grant

Investigating how specific proteins affect kidney cell development

Official title: Role of Etv4 and Etv5 in the self-renewal and differentiation of nephron progenitors

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11113820 · Data updated 2026-11-12

This study is looking at how two proteins, Etv4 and Etv5, help kidney cells grow and develop properly, and it could lead to new treatments for kidney diseases that affect many people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startMay 9, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$445,399
NIH project number5R01DK132052-03
Project IDNIH-11113820 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals with congenital kidney abnormalities or those at risk for kidney diseases.

Less likely to help

Patients with fully developed and healthy kidney function are unlikely to benefit from this research.

What this research studies

This research focuses on the roles of two proteins, Etv4 and Etv5, in the development of kidney cells, particularly nephron progenitor cells. Using a mouse model, the researchers will explore how the absence of these proteins leads to kidney abnormalities and affects the balance between cell self-renewal and differentiation. By analyzing genetic data, they aim to understand the signaling pathways involved in kidney development, which could provide insights into kidney diseases. Patients may benefit from this research as it could lead to new therapeutic strategies for kidney-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for kidney diseases by enhancing our understanding of kidney cell development.

How similar studies have gone: Other research has shown success in understanding kidney development through similar genetic approaches, indicating that this area of study is promising.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Cebrian Ligero, Cristina — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Cebrian Ligero, Cristina

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.